What Is CRISPRoff and How Does It Differ From dCas9-KRAB?

dCas9–KRAB recruits repressive complexes and compacts local chromatin. It silences efficiently, but the state depends on the editor being present and generally reverses when the editor is removed.

CRISPRoff combines KRAB with DNMT3A/3L, so repression is followed by CpG methylation at the targeted region. Because methylation is copied by the maintenance machinery at replication, silencing can persist after the editor is gone — which is the property that distinguishes it.

Same recruitment logic, different durability.

The critical variable is not the repressor but whether CpGs were actually methylated. A CRISPRoff clone that is silent but unmethylated will behave like a KRAB line on passaging.

Neither tool guarantees zero expression.

• • KRAB typically leaves residual transcription, sometimes substantial, depending on promoter architecture and guide placement. Strong, constitutively active promoters are harder to silence fully.
• • CRISPRoff often reduces expression further once methylation is established, and residual expression tends to decline over the first passages. But the outcome still varies by locus and by how densely CpGs are clustered near the target.

Practical consequence: if a screen or model requires near-complete loss, verify with protein-level readout, not mRNA alone, and check at more than one passage.

Choose dCas9–KRAB when:

• • You need fast, reversible knockdown — for example, a CRISPRi screen or a short mechanistic experiment.
• • Full silencing would be lethal or would confound the readout, and partial reduction is what you want.
• • You will want to restore expression without an additional editor.

Choose CRISPRoff when:

• • You are building a durable model: a screening line, a disease model, or an isogenic pair where silencing must survive expansion.
• • You want silencing without a permanent DNA edit, so the locus remains sequence-intact.
• • You need to test whether a phenotype depends on sustained silencing over weeks.

Use both when: you need the causal loop. Silence with CRISPRoff, then reverse with targeted demethylation at the same locus, and show the phenotype follows the mark.

The toxicity point is worth planning for: stable dCas9–KRAB lines vary widely in expression, and high-expression clones can show growth defects unrelated to the target.

Two measurements settle it:

1. Bisulfite or EM-seq at the targeted CpGs. Methylated → you have a CRISPRoff-like state. Unmethylated but silent → KRAB-type repression.
2. Editor withdrawal, then passaging. Silencing that decays indicates editor dependence; silencing that persists indicates a maintained mark.

Both are cheap relative to discovering the difference at the point of publication. Our longer piece on silencing stability sets out the full measurement design.

EDITGENE builds both CRISPRi (dCas9–KRAB) and CRISPRoff lines, with CpG methylation mapping, expression at defined passages, and withdrawal or reversal arms where the claim requires them.

Tell us the gene and the required duration. Contact EDITGENE to request a project consultation or quote.

Silencing efficiency and durability vary by locus, cell type, effector expression level, and guide placement; the comparison here describes general behaviour rather than guaranteed outcomes.

A heritable-silencing claim requires mark-level evidence at the target and a demonstration of persistence after editor withdrawal.

• • Nuñez JK, et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell. 2021;184:2503–2519.
• • Gilbert LA, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013;154:442–451.
• • Amabile A, et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell. 2016;167:219–232.